Literature DB >> 11742932

Predictive value of microalbuminuria in medical ICU patients: results of a pilot study.

O Abid1, Q Sun, K Sugimoto, D Mercan, J L Vincent.   

Abstract

STUDY
OBJECTIVES: To evaluate the predictive value of microalbuminuria in the development of acute respiratory failure (ARF) and multiple organ failure (MOF) in ICU patients.
DESIGN: Prospective, observational study.
SETTING: A 31-bed, mixed medicosurgical ICU in a university hospital. PATIENTS: All adult medical patients admitted to the ICU over a 2-month period, except those receiving nephrotoxic drugs, or those with urologic trauma resulting in frank hematuria or urinary infection, or with existing chronic renal disease (serum creatinine level > or 2.0 mg/dL).
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Urinary samples for microalbumin measurement were collected at hospital admission and at 8, 24, 48, 72, 96, and 120 h after hospital admission. The severity of illness was assessed by the APACHE (acute physiology and chronic health evaluation) II score calculated on the first ICU day, and the degree of organ dysfunction was assessed using the sequential organ failure assessment (SOFA) score. Acute respiratory failure (ARF) was defined as a SOFA respiratory score > or = 3. Patients were separated into two groups according to the trend in microalbuminuria levels over the first 48 h: patients in group 1 had increasing microalbuminuria levels, and patients in group 2 had decreasing microalbuminuria levels. Group 1 included 14 patients in whom microalbuminuria levels increased from 5.2 +/- 2.0 to 19.0 +/- 3.0 mg/dL. Group 2 included 26 patients in whom microalbuminuria levels decreased from 16.4 +/- 4.0 to 7.8 +/- 3.0 mg/dL. The hospital mortality rate was 43% in group 1 and 15% in group 2 (p < 0.05). The APACHE II score and the SOFA score were higher in group 1 than in group 2. The negative predictive value of increasing microalbuminuria was 100% for the development of ARF and 96% for MOF; the positive predictive value of increasing microalbuminuria was 57% for the development of ARF and 50% for MOF.
CONCLUSIONS: Accurate identification of patients destined for ARF and MOF development may enable therapeutic strategies to be applied to limit the disease process. Trend analysis of urinary albumin excretion over the first 48 h of an ICU admission may provide a useful means of identifying such patients. Additional studies need to be performed in larger, mixed patient populations to confirm these findings.

Entities:  

Mesh:

Year:  2001        PMID: 11742932     DOI: 10.1378/chest.120.6.1984

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

1.  Prevalence, predictors and prognostic significance of microalbuminuria in acute cardiac patients: a single center experience.

Authors:  Serafina Valente; Chiara Lazzeri; Marco Chiostri; Bruno Alterini; Agostino Ognibene; Cristina Giglioli; Clara Pigozzi; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2011-05-25       Impact factor: 3.397

2.  Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children.

Authors:  Prasad Devarajan; Catherine D Krawczeski; Mai T Nguyen; Thelma Kathman; Zhu Wang; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2010-10       Impact factor: 8.860

3.  Association of de novo dipstick albuminuria with severe acute kidney injury in critically ill septic patients.

Authors:  Javier A Neyra; John Manllo; Xilong Li; Gordon Jacobsen; Jerry Yee; Lenar Yessayan
Journal:  Nephron Clin Pract       Date:  2015-01-13

Review 4.  Salt of the earth or a drop in the ocean? A pathophysiological approach to fluid resuscitation.

Authors:  P Gosling
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

5.  Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge.

Authors:  Frederic Chagnon; Vishal S Vaidya; Gerard E Plante; Joseph V Bonventre; Alfred Bernard; Chantal Guindi; Olivier Lesur
Journal:  Crit Care Med       Date:  2008-11       Impact factor: 7.598

6.  Microalbuminuria: A novel biomarker of sepsis.

Authors:  Surupa Basu; Mahuya Bhattacharya; Tapan K Chatterjee; Subimal Chaudhuri; Subhash K Todi; Arghya Majumdar
Journal:  Indian J Crit Care Med       Date:  2010-01

7.  Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival.

Authors:  Sangeeta R Hingorani; Kristy Seidel; Armando Lindner; Tia Aneja; Gary Schoch; George McDonald
Journal:  Biol Blood Marrow Transplant       Date:  2008-12       Impact factor: 5.742

8.  Microalbuminuria: An inexpensive, non invasive bedside tool to predict outcome in critically ill patients.

Authors:  Surupa Basu; S Chaudhuri; M Bhattacharyya; T K Chatterjee; S Todi; A Majumdar
Journal:  Indian J Clin Biochem       Date:  2010-05-27

9.  Microalbuminuria does not reflect increased systemic capillary permeability in septic shock.

Authors:  Zsolt Molnár; Tamás Szakmány; Péter Heigl
Journal:  Intensive Care Med       Date:  2003-01-31       Impact factor: 17.440

10.  Proteinuria without albuminuria: urinary protein excretion by a subset of patients with burn injuries.

Authors:  Denis Sviridov; William E Owen; William L Roberts; L S Edelman; Steven K Drake; Glen L Hortin
Journal:  Clin Chim Acta       Date:  2009-01-23       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.